Acquisition by Thompson Tamar of 23248 shares of Catalyst Pharmaceuticals at 21.12 subject to Rule 16b-3
| NSHD Index | 708.00 1,142 61.73% |
About 62% of NYSE Declining's investor base is looking to short. The analysis of the overall investor sentiment regarding NYSE Declining Stocks suggests that many traders are alarmed. NYSE Declining's investing sentiment overview a quick insight into current market opportunities from investing in NYSE Declining Stocks. Many technical investors use NYSE Declining Stocks index news signals to limit their universe of possible portfolio assets and to time the market correctly.
Filed transaction by Catalyst Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
NYSE Declining Stocks Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NYSE Declining index to make a market-neutral strategy. Peer analysis of NYSE Declining could also be used in its relative valuation, which is a method of valuing NYSE Declining by comparing valuation metrics with similar companies.
Peers
NYSE Declining Related Equities
| PH | Parker Hannifin | 1.24 | ||||
| AROW | Arrow Financial | 1.22 | ||||
| UVSP | Univest Pennsylvania | 0.30 | ||||
| JUTOY | Jutal Offshore | 0.00 | ||||
| SLOFF | Solstad Offshore | 0.00 | ||||
| FDVA | Freedom Bank | 0.09 | ||||
| PFLT | PennantPark Floating | 0.28 | ||||
| APOG | Apogee Enterprises | 0.63 |